$43.2 Million is the total value of Founders Fund VII Management, LLC's 2 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | ABCELLERA BIOLOGICS INC | $40,188,000 | +9.2% | 3,773,530 | 0.0% | 93.02% | +2.1% | |
| CMPS | COMPASS PATHWAYS PLCsponsored ads | $3,017,000 | -16.1% | 278,880 | 0.0% | 6.98% | -21.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ABCELLERA BIOLOGICS INC | 12 | Q3 2023 | 94.5% |
| COMPASS PATHWAYS PLC | 12 | Q3 2023 | 20.4% |
View Founders Fund VII Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Founders Fund VII Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.